Evidence map›Paper›PMID 40411343›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2025

Sustainability in translational genomics research with undiagnosed patients: What is it, why do we need it, and how do we do it?

Jennifer L Young, Charis Tang, Lily Liang, Euan A Ashley, Holly K Tabor, Meghan C Halley

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer L YoungCenter for Genetic Medicine, Northwestern University, Evanston, IL.
Charis TangSchool of Law, University of California, Irvine, CA.
Lily LiangStanford Center for Biomedical Ethics, Stanford University, Stanford, CA.
Euan A AshleyDepartment of Medicine, Stanford University, Stanford, CA; Department of Genetics, Stanford University, Stanford, CA.
Holly K TaborStanford Center for Biomedical Ethics, Stanford University, Stanford, CA; Department of Medicine, Stanford University, Stanford, CA; Department of Pediatrics, Stanford University, Stanford, CA; Department of Epidemiology and Population Health, Stanford University, Stanford, CA.
Meghan C HalleyStanford Center for Biomedical Ethics, Stanford University, Stanford, CA; Department of Pediatrics, Stanford University, Stanford, CA. Electronic address: mhalley@stanford.edu.

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
What comes next? Engaging stakeholders in governance of participant data and relationships during the sunset of large genomic medicine research initiativesU01HG010218 · NHGRI · STANFORD UNIVERSITY · PI ASHLEY, EUAN A, BERNSTEIN, JONATHAN ADAM · 2018 to 2022
$6.3M
Center for Undiagnosed Diseases at StanfordU01NS134358 · NINDS · STANFORD UNIVERSITY · PI Jonathan Adam Bernstein, HOLLY K TABOR · 2023 to 2026
$3.1M
Surfacing values in the economic evaluation of genomic sequencing for diagnosis of children with rare diseasesK01HG011341 · NHGRI · STANFORD UNIVERSITY · PI HALLEY, MEGHAN · 2021 to 2025
$868k
A Community-Based Approach for ALDH2 Genetic Testing in East Asian AmericansK01HL173859 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Jennifer Young · 2024 to 2026
$489k
NCATS NIH HHS UL1 TR003142NHGRI NIH HHS K01 HG011341NHGRI NIH HHS U01 HG010218NHLBI NIH HHS K01 HL173859NINDS NIH HHS U01 NS134358
6 · The paper itself

Abstract

purposeGenomics research enrolling undiagnosed patients can provide answers for one-third of participants, and more can be diagnosed through future reanalysis. The long-term value for participants has raised questions of the sustainability of these studies, but the meaning, goals, and best practices for sustainability remain unclear.

methodsWe conducted semistructured interviews with researchers leading studies enrolling undiagnosed patients in the United States and Canada and used thematic content analysis to summarize key themes.

resultsResearchers lacked consensus regarding what sustainability was actually intended to sustain, variably referencing study procedures, personnel, data access, and participant recontact. However, the primary driver of sustainability was widely shared as the perceived obligation to continue to search for answers for undiagnosed participants. Proposed sustainability strategies included diversifying funding sources, developing centralized data infrastructure, and building collaborations across disciplines and institutions. Researchers also emphasized the need to address ethical concerns, to integrate research with clinical care, and for leadership from research funders to guide these efforts.

conclusionAlthough genomics researchers perceived continued obligations to undiagnosed participants, they also lacked a shared understanding of the goals of sustainability and called for coordinated efforts to develop centralized infrastructure that integrated research and clinical care.

Indexed as

GenomicsTranslational Research, BiomedicalCanadaHumansResearch PersonnelUnited StatesFundingGenomicsResearchSustainabilityUndiagnosed

Identifiers

PMID40411343
PMCPMC12318661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.